Aspetar Leads Groundbreaking QSL Study Unveiling 7-Year Fracture Epidemiology in Professional Footballers

26/12/2023 03:58 PM

In a pioneering initiative, Aspetar, Orthopaedic and Sports Medicine Hospital, has spearheaded an unprecedented study on fractures in professional footballers in the Middle East, entitled "Fractures in Professional Footballers: 7-year data from 106 team seasons in the Middle East". The research delves into the intricate details of fractures over seven consecutive seasons (2013-2020) in the Qatar Stars League (QSL), showcasing Aspetar's leadership in the field of injury epidemiology and fracture treatment.

While epidemiological studies on fractures in European professional football were plentiful, vital information on the treatment of fractures had been scarce. The Aspetar study, conducted in collaboration with its unique programmes the ASPREV (Aspetar Injury Prevention) team, and the National Sports Medicine Programme (NSMP) Medical Staff in the QSL league, bridged this gap, providing a significant leap forward in understanding fracture patterns, treatments, and outcomes in the region.

Over seven seasons and 106 team seasons in the QSL, Aspetar studied 3,255 players and 638,247 exposure hours (88.9% training, 11.1% matches).

Fractures accounted for 2.7% of all time-loss injuries, with an incidence of 0.17 fractures per 1,000 exposure hours (0.9 fractures in matches, 0.07 in training).

Common fracture locations included feet (28.2%), hands (21.1%), shoulders (11.3%), and head (9.9%).

Only 34.3% of fractures required surgery, with an average absence from play of 71 days.

Impressively, 98.1% of players returned to professional football, highlighting the success of treatment and rehabilitation strategies.

Dr. Aston Ngai, the lead author, emphasised the study's unique features:

"Our design, led by our experts, combined with Aspetar's data, gives us the only dataset with treatment information not currently available in UEFA data. This allowed us to identify the extent of invasive treatments like surgery, player return to play rates, and reinjury."

Experts at Aspetar expressed concern about lower limb fractures, which often require extended recovery periods and can potentially threaten a player's career. The study sheds light on the possible long-term consequences of fractures, with 4.6% of cases resulting in refractures and one in ten continuing to have symptoms when they returned to play.

This groundbreaking study stands as the most comprehensive fracture analysis outside UEFA, offering unparalleled insights into the unique challenges faced by footballers in the Middle East. Aspetar continues to pave the way in sports medicine research, reinforcing its commitment to advancing the understanding and treatment of sports-related injuries.


About Aspetar:

Aspetar is a world-leading specialised orthopaedic and sports medicine hospital and the first of its kind in the Middle East. Since 2007, with a world expert team, the hospital has provided top-level comprehensive medical treatment to all athletes in a state-of-the-art facility that sets new standards internationally.

In 2009, Aspetar was accredited as a “FIFA Medical Centre of Excellence” by F-MARC. In 2013, Aspetar was adopted as a reference collaborator centre by the Gulf Countries Council (GCC) Health Ministers Council and “The IOC Research Centre for Prevention of Injury and Protection of Athlete Health” in 2014.

In 2015, Aspetar has been recognised as the “IHF Reference Centre for Athlete and Referee Health”. In the same year, the hospital also obtained-on December 15 the Accreditation Canada International (ACI) “Platinum Level”.

Aspetar is a member–organisation of Aspire Zone Foundation, Qatar’s innovative sports and healthy lifestyle destination.

Upcoming Events
Aspetar Wednesday Webinar Series 2024 - 2025

Join us for the 4th year of the Aspetar Wednesday Webinar Series; a unique online learning experience bringing “cutting edge sports medicine and science to your...

Schedule On
15/05/2024 08:00 AM - 16/04/2025 04:00 PM Aspetar
View Details